Browsing Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed by Author "Gamallat, Yaser"
Now showing items 1-2 of 2
-
Exploring the prognostic significance of set-domain containing 2 (setd2) expression in advanced and castrate-resistant prostate cancer
Gamallat, Yaser; Felipe Lima, Joema; Seyedi, Sima; Li, Qiaowang; Rokne, Jon George; Alhajj, Reda; Ghosh, Sunita; Bismar, Tarek A. (2024)SET-domain containing 2 (SETD2) is a histone methyltransferase and an epigenetic modifier with oncogenic functionality. In the current study, we investigated the potential prognostic role of SETD2 in prostate cancer. A ... -
Serrate RNA effector molecule (SRRT) is associated with prostate cancer progression and is a predictor of poor prognosis in lethal prostate cancer
Gamallat, Yaser; Choudhry, Muhammad; Li, Qiaowang; Rokne, Jon George; Alhajj, Reda; Abdelsalam, Ramy; Ghosh, Sunita; Arbet, Jaron; Boutros, Paul C.; Bismar, Tarek A. (MDPI, 2023)Arsenite-resistance protein 2, also known as serrate RNA effector molecule (ARS2/SRRT), is known to be involved in cellular proliferation and tumorigenicity. However, its role in prostate cancer (PCa) has not yet been ...